RFK Jr.’s vaccine panel is laying the groundwork for more scrutiny of childhood shots.

What West Virginia teens lost when CDC cuts ended their fight against Big Tobacco.

The United States and United Kingdom announced a high-level agreement Monday under which the U.K. is expected to pay more for medicines.

When President Kennedy’s newborn son died in 1963, it galvanized research. A new Kennedy family tragedy should spur RFK Jr. to support cancer research, not cut it.

We’re on the ground at the 67th American Society of Hematology Annual Meeting — join us live.

James Watson, the co-discoverer of the structure of DNA who died Thursday at 97, was a scientific legend and a pariah among his peers.

Children’s Health Defense is leveraging its ties to HHS to lock in legal and cultural shifts that could shape policy long after RFK Jr. leaves.

Novo Nordisk's Wegovy, Eli Lilly's Zepbound to be sold at discounted prices on TrumpRx, covered by Medicare.

Appeals court judges’ questions and comments suggested they may be skeptical of Trump administration changes to research overhead payments

Exclusive: Arena Bioworks, the buzzy research institute that launched with $500 million to support a decade of scientific R&D, is abruptly shutting down, STAT has learned.

Texas is the MAHA capital of the country — offering a look at health policies that may soon roll across the country.

This move is a blow to the powerful physician lobby that has long controlled how procedures are priced.

Officials from Colorado, Illinois, Oregon, and Washington say CMS Administrator Mehmet Oz posted incorrect figures about their Medicaid spending on X.

Hope and ‘no regrets’: How pancreatic cancer surgeon Dr. Michael Zinner faced a pancreatic cancer diagnosis

The Trump administration’s posture toward the pharma industry has largely been driven by threats, and a tense negotiation over prices. On Tuesday, in the Oval Office, there was talk of friendship.

Harvard's T.H. Chan School of Public Health faces a harsh new reality: the government is shifting away from funding public health.

Perimenopause brings real symptoms and a booming market of supplements, apps, and therapies. What’s hype, what’s helpful, and what women need to know.

The Trump administration is touting leucovorin as a treatment for autism.

The CDC has rescinded a policy issued on Monday that paused remote work for employees, including those with disabilities

After months of uncertainty, the FDA offered accelerated approval for a treatment for Barth syndrome.

The FDA's crackdown on drug advertising is unprecedented, but some experts questioned whether the agency has the staff to carry it out.

President Trump on Monday urged pharma companies to publicly prove that their Covid-19 products work, saying in a Truth Social post that the CDC is "being ripped apart over this question.”

President Trump on Monday urged pharma companies to publicly prove that their Covid-19 products work, saying in a Truth Social post that the CDC is "being ripped apart over this question.”

The AMA has shifted from a behind-the-scenes lobbying strategy to more forceful public advocacy against President Trump's health care policies.

Insecure about their looks, more men than ever are getting plastic surgery.

Narcan didn’t just magically show up on pharmacy shelves. It exists because people made it happen.

HFO HFO Vinay Prasad returns to a top FDA role just weeks after his abrupt dismissal.

It's not clear why right wing influencers are suddenly pushing back against Medicare reforms.

'They’re not interested in the science': Former NIH nutrition scientist Kevin Hall on how his work with MAHA fell apart.

Americans are binge drinking and smoking tobacco less but consuming marijuana significantly more, according to a new federal survey on drug use and mental health.

With health insurers under pressure, UnitedHealth CEO Stephen Hemsley said that some parts of the business need "fundamental reorientation."

Kennedy and advocates have very different views on how his tenure impacts the community of Americans with disabilities.

“From my perspective — both as someone who’s taken antidepressants, and as a reporter at STAT — the conversation about the drugs demands nuance,” writes @SarahLizChar.

As the Trump administration reshapes biomedicine, it wants to change how scientists test drug safety: animal research.

A 51-year-old man died last month after receiving an experimental treatment from Sarepta, the third death this year tied to the company's gene therapies

In a new study, Nobel laureate David Baker and colleagues detail new methods for targeting undruggable "disordered" proteins.

The idea of making the U.S. more like Europe is anathema to many in the Trump administration. But that’s what the Make America Healthy Again movement says it wants — at least when it comes to food.

Exclusive: HHS devises a legal playbook for future research grant terminations, an internal memo shows.

Late Friday, Senate GOP unveiled changes to health care policies in tax legislation in a bid to win over Republican holdouts and pass muster with budget rules.

Despite his compelling personal story of recovery from addiction, RFK Jr. has said much less about the U.S. drug crisis than other priorities like food additives.

Several hundred NIH employees signed on to a letter rebuking agency actions since the start of President Trump's second term

Budget documents released Friday provide the first clear indication of the priorities of the proposed Administration for a Healthy America

The NIH archives of the Human Genome Project could fall victim to Trump administration cuts, writes a former archivist.

HHS plans to fold the CDC's chronic disease center into the new Administration for a Healthy America. Experts fear for coordination with local health departments, among other things.

Philip Morris is rolling out a heated tobacco product called IQOS in the U.S., concerning researchers and anti-tobacco advocates.

Harvard's Scott Delaney helped build a database of NIH grant terminations that is being used in litigation against the Trump administration.

Some members of the Vaccines and Related Biologics Products Advisory Committee worried that a strain change would require new testing that could delay delivery of vaccines for the fall.

The Andreessen Horowitz-backed companies represented at a meeting with Robert F. Kennedy Jr. include Function Health and Talkiatry.

The grant termination letters say there are no appeals. Yet dozens of appeals have succeeded as biomedical researchers lobby and sue to restore funding.